These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
884 related articles for article (PubMed ID: 21552419)
1. Novel therapeutic strategies for targeting liver cancer stem cells. Oishi N; Wang XW Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419 [TBL] [Abstract][Full Text] [Related]
2. Molecular biology of liver cancer stem cells. Oishi N; Yamashita T; Kaneko S Liver Cancer; 2014 May; 3(2):71-84. PubMed ID: 24944998 [TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma. Jeng KS; Chang CF; Sheen IS; Jeng CJ; Wang CH Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674932 [TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma. Pang RW; Poon RT Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219 [TBL] [Abstract][Full Text] [Related]
5. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression. Liu C; Li J; Wang W; Zhong X; Xu F; Lu J Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway. Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743 [TBL] [Abstract][Full Text] [Related]
7. Zinc finger protein X-linked promotes expansion of EpCAM Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061 [TBL] [Abstract][Full Text] [Related]
8. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC. Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277 [TBL] [Abstract][Full Text] [Related]
9. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. Wu HJ; Chu PY Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710 [TBL] [Abstract][Full Text] [Related]
10. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma. Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764 [TBL] [Abstract][Full Text] [Related]
11. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma. Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612 [TBL] [Abstract][Full Text] [Related]
12. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma. Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681 [TBL] [Abstract][Full Text] [Related]
13. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway. Li B; Liu D; Yang P; Li HY; Wang D Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412 [TBL] [Abstract][Full Text] [Related]
14. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E Cells; 2020 May; 9(5):. PubMed ID: 32408542 [TBL] [Abstract][Full Text] [Related]
16. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907 [TBL] [Abstract][Full Text] [Related]
17. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567 [TBL] [Abstract][Full Text] [Related]
19. miR-365 regulates liver cancer stem cells via RAC1 pathway. Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377 [TBL] [Abstract][Full Text] [Related]
20. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. Sia D; Villanueva A; Friedman SL; Llovet JM Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]